Stocks Comparison
InnovAge vs P3 Health Partners: revenue, profit, margins and growth compared
InnovAge brought in $989.7M of revenue in fiscal 2026, P3 Health Partners $1.5B in fiscal 2024. Revenue changed by +15.9% at InnovAge and -2.8% at P3 Health Partners on the year before, so InnovAge grew faster. InnovAge kept -0.3% of its revenue as net profit, P3 Health Partners -10.1%.
Side by side, latest fiscal year
| INNV | PIII | |
|---|---|---|
| Fiscal year ended | FY2026 (June 30, 2026) | FY2024 (December 31, 2025) |
| Revenue | $989.7M | $1.5B |
| Revenue growth | +15.9% | -2.8% |
| Net income | -$2.5M | -$147.9M |
| Net margin | -0.3% | -10.1% |
| Free cash flow | $50.4M | n/a |
| Free cash flow margin | 5.1% | n/a |
| Earnings per share (diluted) | -$0.02 | -$45.26 |
| Cash | $97.9M | $25M |
| Debt | $48.8M | $273.4M |
| Price to earnings | n/a | n/a |
| Market value | $1.2B | $51.2M |
| Dividend yield | n/a | n/a |
| Rank by revenue in sector | #145 of 523 · Health care | #124 of 523 · Health care |
Over the years
Questions about InnovAge and P3 Health Partners
Which is bigger by revenue, InnovAge or P3 Health Partners?
P3 Health Partners is bigger by revenue: $1.5B in fiscal 2024, against $989.7M for InnovAge in fiscal 2026.
Which keeps more of its revenue as profit, InnovAge or P3 Health Partners?
InnovAge had a net margin of -0.3% in fiscal 2026; P3 Health Partners had -10.1% in fiscal 2024.
Which grew revenue faster, InnovAge or P3 Health Partners?
In their latest fiscal years revenue changed by +15.9% at InnovAge and -2.8% at P3 Health Partners.
Where do these numbers come from?
From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.